Tim Swan advises technology companies on practical approaches to fit their specific needs and goals. He works with life science and software companies on their corporate, commercial and fundraising activities, and brings an understanding of their interaction to each task.
Tim assists clients in understanding, negotiating and closing complex technology transactions. He also helps clients on both buy and sell-side M&A transactions, with a focus on technology dependent targets. In addition, Tim shepherds companies and investors through financings, including convertible notes, SAFEs and preferred equity rounds, and corporate governance matters. Having worked with private equity and venture capital funds, and having advised many of their portfolio companies, Tim is able to succinctly counsel companies as they navigate the unique dynamics of their relationships with investors and owners.
Life Sciences
- Represented a medical device development company in a “build-to-buy” option / merger transaction with a leading strategic in the field, with an enterprise value in excess of $500 million based on the acquisition price.
Startup Venture Capital
- Company side - medical device manufacturer in $120 million Series A round, with multiple financing milestones.
Technology Transactions and Other Matters
- Advised Iridium Communications on a wide range of intellectual property and technology license and development agreements, including the intellectual property aspects of agreements underpinning its current satellite constellation.